PARP Inhibitors and Stratified Treatment of Prostate Cancer

Expert Review of Anticancer Therapy - United Kingdom
doi 10.1080/14737140.2016.1243474
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

PARP Inhibitors in Ovarian Cancer

2013English

Homologous Repair Deficiencies and Current Insights in Clinical Evaluation of PARP Inhibitors in Prostate Cancer

Memo - Magazine of European Medical Oncology
OncologyHematology
2020English

The Inhibition and Treatment of Breast Cancer With Poly (ADP-ribose) Polymerase (PARP-1) Inhibitors

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2006English

PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles

Cancer Cell
Cancer ResearchOncologyCell Biology
2011English

Extending the Scope of PARP Inhibitors in Ovarian Cancer

The Lancet Oncology
Oncology
2019English

Understanding Failure and Improving Treatment Using HDAC Inhibitors for Prostate Cancer

Biomedicines
BiochemistryMedicineGeneticsMolecular Biology
2020English

PARP Inhibitors in Ovarian Cancer: Sensitivity Prediction and Resistance Mechanisms

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

More Breast Cancer Patients Could Benefit From PARP Inhibitors

Cancer
Cancer ResearchOncology
2017English

PARP Inhibitor Treatment in Ovarian and Breast Cancer

Current Problems in Cancer
Cancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy